3.18
3.18 (0%)
As of Mar 21, 2024
Graphite Bio, Inc. [GRPH]
Source:
Company Overview
Graphite Bio, Inc. are a clinical-stage, next-generation gene editing company harnessing high-efficiency targeted gene integration to develop a new class of therapies to potentially cure a wide range of serious and life-threatening diseases.
Country | United States |
Headquarters | south san francisco, california |
Phone Number | (650) 484-0886 |
Industry | |
CEO | Kimberlee C. Drapkin |
Website | www.clinicaltrials.gov |